Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...
Arthritis & Rheumatism
May 22, 2013 |
5 / 5 (2) |
0
|
Gene associated with adolescent idiopathic scoliosis identified
Researchers from the RIKEN Center for Integrative Medical Sciences in Japan have identified the first gene to be associated with adolescent idiopathic scoliosis (also called AIS) across Asian and Caucasian ...
Genetics
May 12, 2013 |
5 / 5 (1) |
0
|
Discovery pinpoints cause of two types of leukemia, providing insights into new treatment approach
(Medical Xpress)—Patients with two forms of leukemia, who currently have no viable treatment options, may benefit from existing drugs developed for different types of cancer, according to a study conducted by researchers ...
Cancer
May 10, 2013 |
5 / 5 (1) |
0
|
Novel RNA-based classification system for colorectal cancer
A novel transcriptome-based classification of colon cancer that improves the current disease stratification based on clinicopathological variables and common DNA markers is presented in a study published in PLOS Medicine this w ...
Cancer
May 21, 2013 |
not rated yet |
0
FDA approves Procysbi for nephropathic cystinosis
(HealthDay)—Procysbi (cysteamine bitartrate) delayed-release capsules have been approved by the U.S. Food and Drug Administration to treat nephropathic cystinosis in children (6 years and up) and adults. ...
Medications
May 02, 2013 |
not rated yet |
0
Cancer studies often lack necessary rigor to answer key questions
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Cancer
Apr 29, 2013 |
5 / 5 (1) |
0
Modified formula aims to prevent death in premature infants
Necrotizing Entercolitis, an infection and inflammation that causes destruction of the intestine,affects about 10,000 babies a year in the country, and mortality rates are roughly 40 percent.
Medical research
May 10, 2013 |
not rated yet |
0
World Malaria Day: Research into a more efficient treatment for 'vivax malaria'
Whilst investment has been increasing in the past years into new treatments for the potentially fatal "malaria tropica", efficient treatment options are still lacking for "vivax malaria". This is a form of ...
Diseases, Conditions, Syndromes
Apr 29, 2013 |
not rated yet |
0
New advances in the management of patients with cirrhosis
New data from clinical studies presented for the first time at the International Liver Congress 2013 provide new rationale for an old and established treatment option for portal hypertension. Additionally, spleen stiffness ...
Diseases, Conditions, Syndromes
Apr 25, 2013 |
not rated yet |
0
